<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the protective effects of Shexiang Xingnaonin (SXN) on focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion injury and its mechanism </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) was used to make focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion model by in travascular nylon filament occlusion </plain></SENT>
<SENT sid="2" pm="."><plain>The protective effects of SXN at different doses were evaluated by investigating neurological function score, pathomorphology of brain, the ultrastructure of neuron, expression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, thrombogenesis in vitro, platelet aggregation and lysing effect of blood clot in vitro </plain></SENT>
<SENT sid="3" pm="."><plain>RESULT: Compared with model group, SXN (0.08, 0.16 g x kg(-1)) could decrease the neurological score, improve pathomorphology and neuron ultrastructure of brain, inhibit the expression of TNF-alpha, decrease the length, wet weight and dry weight of thromb and inhibit platelet aggregation </plain></SENT>
<SENT sid="4" pm="."><plain>And SXN (0.16, 0.32 g x L(-1)) could dissolve blood clot in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: SXN has protective effects on focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion injury </plain></SENT>
<SENT sid="6" pm="."><plain>The role of inhibit the expression of TNF-alpha, inhibit thrombogenesis and platelet aggregation might contribute to its neuroprotective effects </plain></SENT>
</text></document>